相关实验视频

Updated: May 11, 2026

Implantation of the Syncardia Total Artificial Heart

Implantation of the Syncardia Total Artificial Heart

Published on: July 18, 2014

建立一个新的左心室辅助器件计划:从概念到现实

Ehud Jacobzon¹, Avital Lifschitz¹, Danny Fink¹

¹Department of Cardiothoracic Surgery, Shaare Zedek Medical Center, Jerusalem, Israel.

The Israel Medical Association journal : IMAJ

|June 17, 2024

概括

在非移植中心建立新的左心室辅助器件 (LVAD) 计划是可行的. 仔细的规划和患者选择导致先进心力衰竭患者的成功结果.

科学领域:

心脏病学心脏病学
心血管外科心血管外科
医疗器械技术医疗器械技术

背景情况:

左心室辅助器件 (LVAD) 对于高级心力衰竭治疗至关重要.
LVAD植入通常在心脏移植中心进行.
LVADs作为目的地治疗或桥梁的心脏移植.

研究的目的:

详细说明在非心脏移植中心建立一个新的LVAD程序的过程.
介绍前25名LVAD患者的初始短期和长期结果.

主要方法:

计划的建立涉及需求评估,团队组建和协议开发 (手术前,手术期间,手术后,门诊).
与一家知名的心脏移植中心的合作很早就开始了.
强调了细致的患者选择,最初专注于较低风险的个体.

主要成果:

这项研究分析了前25名LVAD患者.
最初的五名患者在两年内没有出现重大并发症而生存.
由于胃肠道出血,发生了一例手术死亡;四例晚期死亡是由于败血症事件造成的.

结论:

在小型和中型中心可以成功实施LVAD计划.
精细的规划使LVAD植入到更多设施的扩展更加容易.
LVAD为更广泛的高级心力衰竭患者提供了可行的治疗选择.

更多相关视频

Use of a Percutaneous Ventricular Assist Device/Left Atrium to Femoral Artery Bypass System for Cardiogenic Shock

Use of a Percutaneous Ventricular Assist Device/Left Atrium to Femoral Artery Bypass System for Cardiogenic Shock

Published on: August 16, 2021

Insertion, Maintenance, and Removal of the Percutaneous Dual Lumen Cannula Right Ventricular Assist Device

Insertion, Maintenance, and Removal of the Percutaneous Dual Lumen Cannula Right Ventricular Assist Device

Published on: July 20, 2022

相关概念视频

Cardiomyopathy V: Interprofessional Care

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...